Summary Population Genetics Technologies Limited (Population Genetics) is a biotechnology company that offers diagnostic test solutions. The company offers products such as diagnostic test kits, HIV diagnostic test systems, and HCV diagnostic test systems. Its diagnostic test kits provide reagent assay kits that include access to cloud-based data analysis through a web interface used in delivery of clinical reports that interpret the sequencing data. The company’s HCV diagnostic test systems are used in mutation verification tagging HCV drug resistance diagnostic tests to target HCV genotypes and significantly improve clinical diagnosis for HCV-infected patients. Population Genetics is headquartered in Cambridge, the UK. Population Genetics Technologies Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value... Research Beam Model: Research Beam Product ID: 548779 250 USD New
Population Genetics Technologies Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Population Genetics Technologies Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : March   2016
  • Pages : 17
  • Publisher : GlobalData
 
 
 
Summary

Population Genetics Technologies Limited (Population Genetics) is a biotechnology company that offers diagnostic test solutions. The company offers products such as diagnostic test kits, HIV diagnostic test systems, and HCV diagnostic test systems. Its diagnostic test kits provide reagent assay kits that include access to cloud-based data analysis through a web interface used in delivery of clinical reports that interpret the sequencing data. The company’s HCV diagnostic test systems are used in mutation verification tagging HCV drug resistance diagnostic tests to target HCV genotypes and significantly improve clinical diagnosis for HCV-infected patients. Population Genetics is headquartered in Cambridge, the UK.

Population Genetics Technologies Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Population Genetics Technologies Limited, Medical Devices Deals, 2010 to YTD 2016 8
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Population Genetics Technologies Secures US$6 Million In Series B Financing 10
Partnerships 12
Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 12
Licensing Agreements 13
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 13
Population Genetics Technologies Limited - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables
List of Tables
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Key Facts 1
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 1
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Population Genetics Technologies Limited, Medical Devices Deals, 2010 to YTD 2016 8
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Population Genetics Technologies Secures US$6 Million In Series B Financing 10
Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 12
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 13
Population Genetics Technologies Limited, Key Competitors 14
Population Genetics Technologies Limited, Key Employees 15

List Of Figures
List of Figures
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Population Genetics Technologies Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Population Genetics Technologies Limited, Medical Devices Deals, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter